Clinical Trial Update: Fibroblast Growth Factor 21 in Systemic Lupus Erythematosus

View source ↗

Summary

A ClinicalTrials.gov listing describes a study evaluating Fibroblast Growth Factor 21 in systemic lupus erythematosus. The trial is currently not yet recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Fibroblast Growth Factor 21 (fibroblast growth factor 21)

Snippet

Sponsor: Assiut University | Conditions: Systemic Lupus Erthematosus | Status: NOT_YET_RECRUITING